Whether it’s care robots, 3D printing of implants or drug delivery systems tailored to the DNA of the individual person — innovations and new health technologies also need an intelligent business model in order to successfully enter a market.
Challenge: In a regulated healthcare market, which in Germany, for example, is financed to around 70 percent by statutory health insurance companies, innovations in both pharmaceuticals and medical technology must do justice to a wide range of stakeholders. Not only must the hurdles of approval be overcome, new therapies must also be reimbursed and, at best, incorporated into medical guidelines and clinical practice in order to be successful with patients and on the market.
Outlook: The course for success or failure in market entry is set very early, often long before the actual market launch. Based on current market information, feasibility studies provide information on the opportunities and risks of new business ideas. Scenarios help to develop strategies for reimbursement or for the “out-of-the-pocket market”. Creative concepts create a unique position in marketing and sales. Cooperations, for example with general practitioners, laboratories, medical supply stores, homecare companies, pharmacies or nursing services, help to design sustainable care concepts.
With many years of experience in all areas of the healthcare ecosystem, Healthcare Shapers support the search for cooperation and sales partners, investors, distributors or potential customers. We provide market information, draw up business plans, develop strategies, for example for reimbursement or for proof of medical evidence. We prepare dossiers, support the negotiation of selective contracts and accompany the implementation during market entry up to operative marketing and sales in the target group of service providers.